Heedo Park

827 total citations
28 papers, 316 citations indexed

About

Heedo Park is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Heedo Park has authored 28 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Heedo Park's work include SARS-CoV-2 and COVID-19 Research (22 papers), SARS-CoV-2 detection and testing (13 papers) and COVID-19 Clinical Research Studies (10 papers). Heedo Park is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (22 papers), SARS-CoV-2 detection and testing (13 papers) and COVID-19 Clinical Research Studies (10 papers). Heedo Park collaborates with scholars based in South Korea, Japan and Puerto Rico. Heedo Park's co-authors include Man‐Seong Park, Sung‐Han Kim, Jiwon Jung, Ji Yeun Kim, Seongman Bae, Jeonghun Kim, So Yun Lim, Jungmin Lee, Joon Seo Lim and Sung Hee Park and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Heedo Park

26 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heedo Park South Korea 9 219 49 48 40 39 28 316
Yannick Galipeau Canada 8 270 1.2× 40 0.8× 51 1.1× 13 0.3× 35 0.9× 26 340
Jianming Zhou China 7 194 0.9× 45 0.9× 52 1.1× 17 0.4× 20 0.5× 13 268
Nicholas Dawe United Kingdom 8 123 0.6× 37 0.8× 39 0.8× 37 0.9× 38 1.0× 16 292
Stéphane Marot France 10 314 1.4× 33 0.7× 49 1.0× 16 0.4× 21 0.5× 32 378
Steve Anderson United States 7 161 0.7× 28 0.6× 69 1.4× 18 0.5× 40 1.0× 13 322
Sandra Hauka Germany 5 406 1.9× 35 0.7× 61 1.3× 12 0.3× 62 1.6× 7 473
Jaiprasath Sachithanandham United States 10 240 1.1× 93 1.9× 32 0.7× 12 0.3× 25 0.6× 36 358
Christine Eucher Belgium 11 474 2.2× 24 0.5× 53 1.1× 17 0.4× 46 1.2× 14 494
Sandrine Van Eeckhoudt Belgium 8 380 1.7× 20 0.4× 41 0.9× 16 0.4× 42 1.1× 11 405
John S. Burke United States 6 258 1.2× 29 0.6× 37 0.8× 18 0.5× 10 0.3× 9 301

Countries citing papers authored by Heedo Park

Since Specialization
Citations

This map shows the geographic impact of Heedo Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heedo Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heedo Park more than expected).

Fields of papers citing papers by Heedo Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heedo Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heedo Park. The network helps show where Heedo Park may publish in the future.

Co-authorship network of co-authors of Heedo Park

This figure shows the co-authorship network connecting the top 25 collaborators of Heedo Park. A scholar is included among the top collaborators of Heedo Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heedo Park. Heedo Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seok, Hyeri, Joon‐Yong Bae, Won Suk Choi, et al.. (2025). Effectiveness and Immunogenicity of the MMR Vaccine Against SARS-CoV-2 Among Healthcare Workers. Viruses. 17(2). 215–215.
2.
Kim, Jihye, Ji Yun Noh, Jin Nam Kim, et al.. (2024). Omicron BA.2 breakthrough infection elicits CD8 + T cell responses recognizing the spike of later Omicron subvariants. Science Immunology. 9(91). eade6132–eade6132. 7 indexed citations
3.
Kim, Dongbum, Jin-Soo Kim, Heedo Park, et al.. (2024). Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model. Virus Genes. 60(3). 251–262. 2 indexed citations
4.
Kim, Dongbum, Minyoung Kim, Jin-Soo Kim, et al.. (2024). A mouse xenograft long‐term replication yields a SARS‐CoV‐2 Delta mutant with increased lethality. Journal of Medical Virology. 96(2). e29459–e29459. 2 indexed citations
5.
Nham, Eliel, Jungmin Lee, Heedo Park, et al.. (2023). Low Neutralizing Activities to the Omicron Subvariants BN.1 and XBB.1.5 of Sera From the Individuals Vaccinated With a BA.4/5-Containing Bivalent mRNA Vaccine. Immune Network. 23(6). e43–e43. 5 indexed citations
6.
Park, Heedo, et al.. (2023). Phylodynamics and Molecular Mutations of the Hemagglutinin Affecting Global Transmission and Host Adaptation of H5Nx Viruses. Transboundary and Emerging Diseases. 2023. 1–14. 2 indexed citations
7.
Kim, Dongbum, Jin-Soo Kim, Minyoung Kim, et al.. (2023). Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2. Frontiers in Cellular and Infection Microbiology. 13. 1280686–1280686. 6 indexed citations
8.
Lee, Kyuyoung, Joon‐Yong Bae, Heedo Park, et al.. (2023). Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea. iScience. 26(9). 107689–107689.
10.
Jung, Jiwon, Jungmin Lee, Heedo Park, et al.. (2022). Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient. Journal of Korean Medical Science. 37(17). e133–e133. 8 indexed citations
11.
Kim, Yoonjung, Joon‐Yong Bae, Ki Tae Kwon, et al.. (2022). Kinetics of neutralizing antibodies against SARS-CoV-2 infection according to sex, age, and disease severity. Scientific Reports. 12(1). 13491–13491. 5 indexed citations
12.
Jung, Jiwon, Jungmin Lee, Sun-Kyung Kim, et al.. (2022). Evaluation of In-Hospital Cluster of COVID-19 Associated With a Patient With Prolonged Viral Shedding Using Whole-Genome Sequencing. Journal of Korean Medical Science. 37(39). e289–e289. 2 indexed citations
13.
Kim, Ji Yeun, Heedo Park, So Yun Lim, et al.. (2022). Comparison of secondary attack rate and viable virus shedding between patients with SARS‐CoV‐2 Delta and Omicron variants: A prospective cohort study. Journal of Medical Virology. 95(1). e28369–e28369. 13 indexed citations
14.
Bae, Seongman, Heedo Park, Ji Yeun Kim, et al.. (2022). Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19. Frontiers in Medicine. 9. 922431–922431. 1 indexed citations
15.
Park, Heedo, et al.. (2022). Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines. The Journal of Microbiology. 60(3). 308–320. 5 indexed citations
16.
Park, Heedo, Ji Yeun Kim, Sung Hee Park, et al.. (2022). Clinical scoring system to predict viable viral shedding in patients with COVID-19. Journal of Clinical Virology. 157. 105319–105319. 6 indexed citations
17.
Hwang, Hyun Jung, Yeon-Gil Choi, Joori Park, et al.. (2021). TRIM28 functions as a negative regulator of aggresome formation. Autophagy. 17(12). 4231–4248. 15 indexed citations
18.
Kim, Doyeon, Sukjun Kim, Joori Park, et al.. (2021). A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome. Nature Communications. 12(1). 5120–5120. 47 indexed citations
19.
Kim, Ji Yeun, Joon‐Yong Bae, Seongman Bae, et al.. (2021). Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19. Clinical Microbiology and Infection. 28(1). 101–106. 29 indexed citations
20.
Bae, Joon‐Yong, et al.. (2021). The Immune Correlates of Orthohantavirus Vaccine. Vaccines. 9(5). 518–518. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026